NCT00037388View on ClinicalTrials.gov

Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II

CompletedOBSERVATIONAL
Timeline

Start Date

July 31, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Blood DiseaseAnemia, Sickle CellChlamydia InfectionsCerebrovascular Accident
All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00037388 - Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II | Biotech Hunter | Biotech Hunter